00000000|MMI|3.75|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.75|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.68|Clipperton Island|C4050020|[geoa]|["CP"-tx-1-"CP"-noun-0]|TX|74/2|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|114/13|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.50|Atypical|C0205182|[qlco]|["Atypical"-tx-1-"atypical"-adj-0]|TX|65/8|
00000000|MMI|3.50|atypia morphology|C0741302|[fndg]|["Atypical"-tx-1-"atypical"-adj-0]|TX|65/8|
00000000|MMI|3.49|6/4|C0442748|[fndg]|["6/4"-tx-1-"6/4"-fraction-0]|TX|105/3|
00000000|MMI|3.48|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|3.48|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|101.48|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-31-"DISCHARGE"-noun-0,"Discharge"-tx-30-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Patient Discharge"-tx-2-"DISCHARGE PATIENT"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5077/9;4939/9;1263/9;107/17;38/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|90.35|Portugal|C0032729|[geoa]|["PO"-tx-3-"PO"-noun-0]|TX|[359/2],[436/2],[479/2],[629/2],[805/2],[912/2],[988/2],[1051/2]|Z01.542.727
00000000|MMI|84.93|Metformin|C0025598|[orch,phsu]|["METFORMIN"-tx-28-"metformin"-noun-0,"METFORMIN"-tx-24-"metformin"-noun-0,"METFORMIN"-tx-20-"metformin"-noun-0,"METFORMIN"-tx-14-"metformin"-noun-0,"METFORMIN"-tx-3-"METFORMIN"-noun-0]|TX|4856/9;4647/9;4451/9;2850/9;967/9|D02.078.370.141.450
00000000|MMI|68.28|Coding|C0009219|[ocac]|["code"-tx-25-"CODE"-noun-0,"code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|4694/4;262/4;280/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|63.86|Hypercholesterolemia|C0020443|[dsyn]|["HYPERCHOLESTEROLEMIA"-tx-14-"hypercholesterolemia"-noun-0,"HYPERCHOLESTEROLEMIA"-tx-3-"hypercholesterolemia"-noun-0]|TX|2660/20;[1518/20],[1743/20]|C18.452.584.500.500.396
00000000|MMI|58.08|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-14-"asa"-noun-0,"ASPIRIN"-tx-3-"ASPIRIN"-noun-0]|TX|2786/3;404/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|57.81|Obesity|C0028754|[dsyn]|["OBESE"-tx-14-"obese"-adj-0,"OBESE"-tx-14-"obese"-adj-1]|TX|[3064/5],[3188/5];[3064/5],[3188/5]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|57.05|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-24-"Pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-19-"pt"-noun-0,"PT"-tx-17-"Pt"-noun-0,"PT"-tx-14-"pt"-noun-0,"PT"-tx-13-"Pt"-noun-0,"PT"-tx-9-"pt"-noun-0,"PT"-tx-8-"Pt"-noun-0,"PT"-tx-7-"pt"-noun-0,"PT"-tx-6-"Pt"-noun-0,"PT"-tx-4-"pt"-noun-0]|TX|4615/2;4479/2;4333/2;4135/2;3943/2;2485/2;2213/2;2106/2;2046/2;1941/2;1834/2|
00000000|MMI|57.05|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-24-"Pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-19-"pt"-noun-0,"PT"-tx-17-"Pt"-noun-0,"PT"-tx-14-"pt"-noun-0,"PT"-tx-13-"Pt"-noun-0,"PT"-tx-9-"pt"-noun-0,"PT"-tx-8-"Pt"-noun-0,"PT"-tx-7-"pt"-noun-0,"PT"-tx-6-"Pt"-noun-0,"PT"-tx-4-"pt"-noun-0]|TX|4615/2;4479/2;4333/2;4135/2;3943/2;2485/2;2213/2;2106/2;2046/2;1941/2;1834/2|
00000000|MMI|53.60|Dyspnea|C0013404|[sosy]|["SOB"-tx-30-"SOB"-noun-0,"SOB"-tx-19-"SOB"-noun-0,"SOB"-tx-5-"sob"-noun-0,"SOB"-tx-4-"sob"-noun-0]|TX|4919/3;4393/3;1931/3;1847/3|C08.618.326;C23.888.852.371
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1239/9],[1352/9]|x.x.x.x.x.x.x
00000000|MMI|46.82|Daily|C0332173|[tmco]|["QD"-tx-14-"qd"-adv-0,"QD"-tx-14-"qd"-noun-0,"Daily"-tx-3-"DAILY"-adj-0]|TX|[2781/2],[2793/2],[2812/2],[2829/2],[2917/2],[2937/2];[2781/2],[2793/2],[2812/2],[2829/2],[2917/2],[2937/2];[439/5],[513/5],[1013/5],[1054/5]|
00000000|MMI|45.60|Walking (activity)|C0080331|[dora]|["Walking"-tx-8-"walking"-verb-0,"Walking"-tx-3-"Walking"-noun-0]|TX|2123/7;1150/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|45.03|Oxycodone|C0030049|[orch,phsu]|["OXYCODONE"-tx-14-"oxycodone"-noun-0,"OXYCODONE"-tx-3-"OXYCODONE"-noun-0]|TX|2767/9;790/9|D03.132.577.249.562.149.575;D03.549.686.607.204.650;D03.605.497.607.204.650;D04.615.723.795.576.149.575
00000000|MMI|42.15|Sleep Apnea, Obstructive|C0520679|[dsyn]|["OSA"-tx-14-"OSA"-noun-0,"OSA"-tx-3-"OSA"-noun-0]|TX|2632/3;1489/3|C08.618.085.852.850;C10.886.425.800.750.850
00000000|MMI|39.37|Mongolia|C0026410|[geoa]|["MG"-tx-3-"MG"-noun-0]|TX|[356/2],[433/2],[1048/2]|Z01.252.474.651
00000000|MMI|39.03|Hepatolenticular Degeneration|C0019202|[dsyn]|["WD"-tx-14-"wd"-noun-0]|TX|[2845/2],[2883/2]|C06.552.413;C10.228.140.079.493;C10.228.140.163.100.360;C10.228.662.400;C10.574.500.487;C16.320.400.361;C16.320.565.189.360;C16.320.565.618.403;C18.452.132.100.360;C18.452.648.189.360;C18.452.648.618.403
00000000|MMI|38.74|District of Columbia|C0012764|[geoa]|["D.C."-tx-24-"d/c"-noun-0,"D.C."-tx-2-"D/C"-noun-0]|TX|4626/3;184/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|38.69|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-14-"atenolol"-noun-0,"ATENOLOL"-tx-3-"ATENOLOL"-noun-0]|TX|2798/8;995/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|35.81|Togo|C0040363|[geoa]|["TO"-tx-17-"to"-adv-0,"TO"-tx-8-"to"-adv-0]|TX|4206/2;2185/2|Z01.058.290.190.800
00000000|MMI|35.81|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-17-"to"-adv-0,"TO"-tx-8-"to"-adv-0]|TX|4206/2;2185/2|D08.811.520.224.800
00000000|MMI|35.02|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-14-"HTN"-noun-0,"HTN"-tx-3-"HTN"-noun-0,"HTN"-tx-3-"htn"-noun-0]|TX|2654/3;1737/3;1512/3|C14.907.489
00000000|MMI|32.91|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-14-"EKG"-noun-0,"EKG"-tx-14-"EKG"-noun-1]|TX|[3295/3],[4000/3];[3295/3],[4000/3]|E01.370.370.380.240;E01.370.405.240
00000000|MMI|32.91|Electrocardiography|C1623258|[diap]|["EKG"-tx-14-"EKG"-noun-0]|TX|[3295/3],[4000/3]|E01.370.370.380.240;E01.370.405.240
00000000|MMI|32.91|Prevacid|C0286036|[orch,phsu]|["Prevacid"-tx-14-"prevacid"-noun-0,"Prevacid"-tx-3-"PREVACID"-noun-0]|TX|2888/8;1019/8|D02.886.640.074.249;D03.383.725.024.249;D03.438.103.034.249
00000000|MMI|32.84|Pain|C0030193|[sosy]|["PAIN"-tx-14-"pain"-noun-1,"PAIN"-tx-7-"pain"-noun-0]|TX|3163/4;2027/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|32.63|Saint Lucia|C0036056|[geoa]|["ST"-tx-14-"ST"-noun-0,"ST"-tx-1-"St"-noun-0]|TX|3378/2;90/2|Z01.107.084.900.825;Z01.639.880.825
00000000|MMI|32.58|Records|C0034869|[inpr]|["Record"-tx-28-"record"-noun-0,"Records"-tx-10-"records"-noun-0]|TX|4831/6;2338/7|E05.318.308.940;L01.280.900;N04.452.859;N05.715.360.300.715;N06.850.520.308.940
00000000|MMI|32.41|Enalapril Maleate|C0700452|[aapp,phsu]|["ENALAPRIL MALEATE"-tx-3-"ENALAPRIL MALEATE"-noun-0]|TX|[486/17],[685/17]|D12.644.456.345.360
00000000|MMI|32.38|Clipperton Island|C4050020|[geoa]|["CP"-tx-30-"CP"-noun-0,"CP"-tx-13-"CP"-noun-0,"CP"-tx-8-"CP"-noun-0,"CP"-tx-4-"cp"-noun-0,"CP"-tx-3-"CP"-noun-0]|TX|4916/2;2581/2;2161/2;1856/2;[1250/2],[1341/2],[1669/2],[1779/2]|
00000000|MMI|32.32|Dominican Republic|C0013014|[geoa]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-3-"Dr"-noun-0]|TX|4738/2;1199/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|31.91|Oral|C0442027|[spco]|["PO"-tx-3-"PO"-noun-0]|TX|[359/2],[436/2],[479/2],[629/2],[805/2],[912/2],[988/2],[1051/2]|
00000000|MMI|29.46|Needs|C0027552|[qlco]|["Needed"-tx-19-"needed"-verb-0,"Needed"-tx-17-"needed"-verb-0]|TX|4322/6;4253/6|N03.349.380.420;N05.300.450
00000000|MMI|29.46|OSA protein, Drosophila|C0764906|[aapp,bacs]|["OSA"-tx-14-"OSA"-noun-0,"OSA"-tx-3-"OSA"-noun-0]|TX|2632/3;1489/3|x.x.x.x
00000000|MMI|26.36|Diet|C0012155|[food]|["Diet"-tx-21-"diet"-noun-0,"Diet"-tx-3-"DIET"-noun-0]|TX|4576/4;1060/4|G07.203.650.240
00000000|MMI|26.26|Rabbi|C0684010|[prog]|["R."-tx-14-"r"-noun-0,"R."-tx-3-"R"-noun-0]|TX|3143/1;1622/1|M01.526.799.500
00000000|MMI|26.06|ECHO protocol|C0058928|[topp]|["ECHO"-tx-15-"ECHO"-noun-0,"ECHO"-tx-14-"ECHO"-noun-0]|TX|4059/4;3430/4|x.x.x.x
00000000|MMI|26.05|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-24-"d/c"-noun-0,"D & C"-tx-2-"D/C"-noun-0]|TX|4626/3;184/3|E04.157.310;E04.950.300.299
00000000|MMI|25.97|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-24-"baseline"-noun-0,"baseline"-tx-16-"Baseline"-noun-0]|TX|4638/8;4105/8|x.x.x.x
00000000|MMI|25.97|Physicians|C0031831|[prog]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-3-"Dr"-noun-0]|TX|4738/2;1199/2|M01.526.485.810;N02.360.810
00000000|MMI|25.54|Residual volume|C0035190|[clna]|["RV"-tx-14-"RV"-noun-0]|TX|3504/2|E01.370.386.700.485.750.275.650;G09.772.850.390.820
00000000|MMI|25.51|Peptide Elongation Factor 2|C0059037|[aapp,enzy]|["EF 2"-tx-14-"2 EF"-noun-0]|TX|3435/1,3458/2|D08.811.277.040.330.300.100.102;D12.776.157.325.150.102;D12.776.835.700.350.102
00000000|MMI|22.61|Surgical aspects|C0038895|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1551/10|x.x.x.x.x.x.x
00000000|MMI|22.57|risk factors|C0035648|[qnco]|["Risk Factors"-tx-3-"risk factors"-noun-0]|TX|1698/12|E05.318.740.600.800.725;N05.715.350.200.700;N05.715.360.750.625.700.700;N06.850.490.625.750;N06.850.520.830.600.800.725
00000000|MMI|22.40|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-14-"asa"-noun-0]|TX|2786/3|D08.811.277.352.827.070.250
00000000|MMI|22.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1414/9|x.x.x.x.x.x.x
00000000|MMI|22.36|Chimerin 1|C0067895|[aapp,bacs]|["NC"-tx-18-"NC"-noun-0]|TX|4279/2|D12.644.360.325.150.100.200;D12.776.476.325.150.100.200;D12.776.641.124.200
00000000|MMI|20.95|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-3-"DOCUSATE SODIUM"-noun-0]|TX|454/15|D02.241.081.337.759.249
00000000|MMI|20.95|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-14-"NAD"-noun-0]|TX|3033/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|20.47|Disruptive, Impulse Control, and Conduct Disorders|C0021122|[mobd]|["ICD"-tx-14-"ICD"-noun-0,"ICD"-tx-9-"ICD"-noun-0,"ICD"-tx-3-"ICD"-noun-0]|TX|2609/3;2262/3;1443/3|F03.250
00000000|MMI|20.17|Disease|C0012634|[dsyn]|["condition"-tx-30-"CONDITION"-noun-0,"condition"-tx-3-"Conditions"-noun-0]|TX|4949/9;1362/10|C23.550.288
00000000|MMI|20.05|Tobacco use|C0543414|[inbe]|["TOBACCO USE"-tx-14-"tobacco use"-noun-0,"TOBACCO USE"-tx-3-"tobacco use"-noun-0]|TX|2714/11;1723/11|F01.145.958
00000000|MMI|20.01|Diet therapy|C0012159|[hlca]|["Diet"-tx-21-"diet"-noun-0,"Diet"-tx-3-"DIET"-noun-0]|TX|4576/4;1060/4|E02.642.249
00000000|MMI|19.89|Order (action)|C1705178|[acty]|["Order"-tx-31-"ORDERS"-verb-0,"Ordered"-tx-21-"ordered"-verb-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5087/6;4581/7;597/5;188/5;48/6|
00000000|MMI|19.89|Order (arrangement)|C1705176|[qlco]|["Order"-tx-31-"ORDERS"-verb-0,"Ordered"-tx-21-"ordered"-verb-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5087/6;4581/7;597/5;188/5;48/6|
00000000|MMI|19.67|Patient Monitoring|C0030695|[hlca]|["monitor"-tx-28-"Monitor"-noun-0,"monitor"-tx-23-"Monitored"-adj-0]|TX|4799/7;4599/9|E01.370.520
00000000|MMI|19.38|Colace|C0282139|[orch,phsu]|["Colace"-tx-3-"COLACE"-noun-0]|TX|445/6|D02.241.081.337.759.249
00000000|MMI|19.31|Ativan|C0699194|[orch,phsu]|["Ativan"-tx-19-"ativan"-noun-0]|TX|4346/6|D03.438.079.080.070.450
00000000|MMI|19.30|Exercise|C0015259|[dora]|["Exercise"-tx-7-"exercising"-noun-0]|TX|2049/10|G11.427.590.530.698.277;I03.350
00000000|MMI|19.27|3,4-Methylenedioxyamphetamine|C0000379|[orch,phsu]|["MDA"-tx-3-"mda"-noun-0]|TX|749/3|D02.092.471.683.152.660
00000000|MMI|19.23|Lovenox|C0728963|[orch,phsu]|["Lovenox"-tx-25-"lovenox"-noun-0]|TX|4672/7|D09.698.373.400.300.200
00000000|MMI|19.23|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-25-"nexium"-noun-0]|TX|4682/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|19.23|Delaware|C0011198|[geoa]|["DE"-tx-1-"De"-noun-0]|TX|87/2|Z01.107.567.875.500.200
00000000|MMI|19.21|North Carolina|C0028407|[geoa]|["NC"-tx-18-"NC"-noun-0]|TX|4279/2|Z01.107.567.875.075.475;Z01.107.567.875.750.530
00000000|MMI|18.24|NRL gene|C1417848|[gngm]|["NRL"-tx-14-"nrl"-noun-0]|TX|[3500/3],[3727/3],[3748/3],[3800/3],[3818/3]|
00000000|MMI|17.80|Acetaminophen|C0000970|[orch,phsu]|["ACETAMINOPHEN"-tx-3-"ACETAMINOPHEN"-noun-0]|TX|336/13|D02.065.199.092.040
00000000|MMI|17.80|Diabetes Mellitus, Non-Insulin-Dependent|C0011860|[dsyn]|["Diabetes mellitus type 2"-tx-3-"diabetes mellitus type 2"-noun-0]|TX|1462/24|C18.452.394.750.149;C19.246.300
00000000|MMI|17.80|Tylenol|C0699142|[orch,phsu]|["Tylenol"-tx-3-"TYLENOL"-noun-0]|TX|326/7|D02.065.199.092.040
00000000|MMI|17.80|lansoprazole|C0050940|[orch,phsu]|["LANSOPRAZOLE"-tx-3-"LANSOPRAZOLE"-noun-0]|TX|1030/12|D02.886.640.074.249;D03.383.725.024.249;D03.438.103.034.249
00000000|MMI|16.12|Hydrocephalus, Normal Pressure|C0020258|[dsyn]|["NPH"-tx-20-"NPH"-noun-0]|TX|4506/3|C10.228.140.602.750
00000000|MMI|16.10|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-3-"POTASSIUM CHLORIDE"-noun-0]|TX|709/18|D01.210.450.150.750;D01.745.625
00000000|MMI|16.09|Enalapril|C0014025|[aapp,phsu]|["ENALAPRIL"-tx-14-"enalapril"-noun-0]|TX|2871/9|D12.644.456.345.360
00000000|MMI|16.09|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-14-"lipitor"-noun-0]|TX|2834/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|16.08|Thymopentin|C0080225|[aapp,bacs,phsu]|["TP-5"-tx-3-"TP 5"-noun-0]|TX|782/2,800/1|D06.472.910.800.850
00000000|MMI|16.07|Headache|C0018681|[sosy]|["HEADACHE"-tx-3-"Headache"-noun-0]|TX|370/8|C10.597.617.470;C23.888.592.612.441
00000000|MMI|16.05|New Caledonia|C0027964|[geoa]|["NC"-tx-18-"NC"-noun-0]|TX|4279/2|Z01.639.760.590.620
00000000|MMI|16.04|Nocturia|C0028734|[dsyn]|["NOCTURIA"-tx-13-"nocturia"-noun-0]|TX|2527/8|C23.888.942.343.550
00000000|MMI|16.04|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-24-"regimen"-noun-0]|TX|4657/7|E02.183;N05.715.360.775.225
00000000|MMI|16.04|Fluorides|C0016327|[inch,phsu]|["F-"-tx-13-"f"-noun-0]|TX|2555/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|16.04|Latvia|C0023128|[geoa]|["LV"-tx-14-"LV"-noun-0]|TX|3447/2|Z01.542.248.136.560;Z01.586.950.140.560
00000000|MMI|15.79|Hypercholesterolemia result|C1522133|[fndg]|["Hypercholesterolemia"-tx-14-"hypercholesterolemia"-noun-0,"Hypercholesterolemia"-tx-3-"hypercholesterolemia"-noun-0]|TX|2660/20;[1518/20],[1743/20]|
00000000|MMI|15.79|Override|C1547671|[acty]|["Override"-tx-3-"Override"-verb-0,"Override"-tx-3-"override"-verb-0]|TX|[519/8],[536/8];739/8|
00000000|MMI|15.41|Order (document)|C1705175|[inpr]|["Order"-tx-31-"ORDERS"-verb-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5087/6;597/5;188/5;48/6|
00000000|MMI|15.41|Order (taxonomic)|C1705177|[clas]|["Order"-tx-31-"ORDERS"-verb-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5087/6;597/5;188/5;48/6|
00000000|MMI|15.41|Permutation|C1882348|[qlco]|["Order"-tx-31-"ORDERS"-verb-0,"Order"-tx-3-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5087/6;597/5;188/5;48/6|
00000000|MMI|15.41|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-31-"ORDERS"-verb-0,"ORDER"-tx-3-"order"-noun-0,"ORDER"-tx-2-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5087/6;597/5;188/5;48/6|
00000000|MMI|14.78|Normal|C0205307|[qlco]|["Unremarkable"-tx-17-"unremarkable"-adj-0,"NORMAL"-tx-14-"Normal"-adj-0,"NORMAL"-tx-14-"normal"-adj-0,"Unremarkable"-tx-12-"unremarkable"-adj-0]|TX|4177/12;3440/6;3634/6;2471/12|
00000000|MMI|14.64|Aortic Valve Insufficiency|C0003504|[dsyn]|["AORTIC REGURGITATION"-tx-14-"aortic regurgitation"-noun-1]|TX|3569/20|C14.280.484.095
00000000|MMI|14.64|Aortic valve structure|C0003501|[bpoc]|["AORTIC VALVE"-tx-14-"aortic valve"-noun-0]|TX|3534/12|A07.541.510.110
00000000|MMI|14.64|Consultation|C0009818|[hlca]|["consulted"-tx-17-"consulted"-verb-0]|TX|4196/9|N04.452.758.849
00000000|MMI|14.64|Endometriosis|C0014175|[dsyn]|["Endo"-tx-20-"Endo"-adj-0]|TX|4410/4|C13.351.500.163
00000000|MMI|14.64|Mental Depression|C0011570|[mobd]|["DEPRESSION"-tx-3-"depression"-noun-0]|TX|1449/10|F01.145.126.350
00000000|MMI|14.64|Paraguay|C0030428|[geoa]|["PA"-tx-31-"PA"-noun-0]|TX|5033/2|Z01.107.757.656
00000000|MMI|14.64|Set (Psychology)|C0036849|[menp]|["Set"-tx-14-"sets"-verb-1]|TX|3416/4|F02.463.425.838
00000000|MMI|14.64|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-14-"PE"-noun-0]|TX|2960/2|x.x.x.x
00000000|MMI|14.58|size|C0456389|[spco]|["Size"-tx-14-"size"-noun-0]|TX|[3510/4],[3771/4],[3807/4],[3822/4]|
00000000|MMI|14.57|Preventive monitoring|C0150369|[hlca]|["monitor"-tx-28-"Monitor"-noun-0,"monitor"-tx-23-"Monitored"-adj-0,"Monitoring"-tx-15-"monitoring"-noun-0,"Monitoring"-tx-14-"monitoring"-noun-0]|TX|4799/7;4599/9;4032/10;3962/10|
00000000|MMI|14.56|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-31-"DISCHARGE"-noun-0,"Discharge"-tx-30-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5077/9;4939/9;1263/9;38/9|
00000000|MMI|14.56|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-31-"DISCHARGE"-noun-0,"Discharge"-tx-30-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5077/9;4939/9;1263/9;38/9|
00000000|MMI|14.42|Home environment|C0442519|[cnce]|["HOME"-tx-24-"home"-noun-0,"HOME"-tx-14-"Home"-noun-0,"HOME"-tx-3-"Home"-noun-0,"house"-tx-3-"House"-noun-0]|TX|4630/4;2756/4;298/4;1066/5|
00000000|MMI|13.35|Heart|C0018787|[bpoc]|["Cardiac"-tx-21-"cardiac"-adj-0,"Cardiac"-tx-3-"cardiac"-adj-0]|TX|4568/7;1690/7|A07.541
00000000|MMI|13.22|Mitral Valve Insufficiency|C0026266|[patf]|["MITRAL REGURGITATION"-tx-14-"mitral regurgitation"-noun-1]|TX|3598/20|C14.280.484.461
00000000|MMI|13.22|Pulmonary valve structure|C0034086|[bpoc]|["PULMONIC VALVE"-tx-14-"pulmonic valve"-noun-0]|TX|3731/14|A07.541.510.738
00000000|MMI|13.14|Fentanyl|C0015846|[orch,phsu]|["FENTANYL"-tx-3-"FENTANYL"-noun-0]|TX|753/8|D03.383.621.265
00000000|MMI|13.10|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-20-"held"-verb-0]|TX|4461/4|x.x.x.x
00000000|MMI|13.09|Mirtazapine|C0049506|[orch,phsu]|["MIRTAZAPINE"-tx-14-"mirtazapine"-noun-0]|TX|2922/11|x.x.x.x
00000000|MMI|13.09|Solomon Islands|C0037623|[geoa]|["BP"-tx-14-"BP"-noun-0]|TX|3004/2|Z01.639.760.590
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-30-"PLAN"-noun-0]|TX|4973/4|C10.228.140.744
00000000|MMI|13.04|Tricuspid Valve Insufficiency|C0040961|[dsyn]|["TRICUSPID VALVE, REGURGITATION"-tx-14-"tricuspid valve regurgitation"-noun-1]|TX|3641/15,3679/13|C14.280.484.856
00000000|MMI|12.96|Gastritis|C0017152|[dsyn]|["GASTRITIS"-tx-3-"gastritis"-noun-0]|TX|1541/9|C06.405.205.697;C06.405.748.398
00000000|MMI|12.96|Moldova|C0026374|[geoa]|["MDA"-tx-3-"mda"-noun-0]|TX|749/3|Z01.542.248.540;Z01.586.200.540;Z01.586.950.540
00000000|MMI|12.94|National Academy of Sciences (U.S.)|C0027446|[orgt]|["NAS"-tx-3-"NAS"-noun-0]|TX|1074/3|N03.540.052.500
00000000|MMI|12.94|Terazosin|C0076107|[orch,phsu]|["TERAZOSIN"-tx-14-"terazosin"-noun-0]|TX|2817/9|x.x.x.x
00000000|MMI|12.91|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-28-"PCP"-noun-0]|TX|4842/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|12.90|Oxygen|C0030054|[elii,phsu]|["O2"-tx-18-"O2"-noun-0]|TX|4268/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|12.90|Panama|C0030266|[geoa]|["PM"-tx-2-"PM"-adj-0]|TX|145/2|Z01.107.169.772
00000000|MMI|12.89|Palpation|C0030247|[diap]|["PALPATION"-tx-14-"palpation"-noun-0]|TX|3173/9|E01.370.600.600
00000000|MMI|11.92|Hospital admission|C0184666|[hlca]|["Admit"-tx-20-"admit"-verb-0,"Admission"-tx-3-"Admission"-noun-0,"Admit"-tx-3-"ADMIT"-verb-0]|TX|4469/5;1320/9;1233/5|
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1220/7|H02.403.044
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-3-"Complications"-noun-0]|TX|1388/13|x.x.x
00000000|MMI|11.49|Depressive disorder|C0011581|[mobd]|["-- Depression"-tx-3-"depression"-noun-0]|TX|1449/10|F03.600.300
00000000|MMI|11.49|Edema|C0013604|[fndg]|["OEDEMA"-tx-14-"edema"-noun-1]|TX|3243/5|C23.888.277
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1566/10|x.x.x
00000000|MMI|11.49|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-14-"Neuro"-adj-0]|TX|3249/5|H02.403.600
00000000|MMI|11.49|Pericardial effusion|C0031039|[dsyn]|["Effusion, Pericardial"-tx-14-"pericardial effusion"-noun-1]|TX|3853/20|C14.280.695
00000000|MMI|11.49|Pseudodementia|C0033797|[mobd]|["Pseudodementia"-tx-3-"pseudodementia"-noun-0]|TX|1495/14|F03.875.375
00000000|MMI|11.12|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-16-"CV"-noun-0,"CV"-tx-14-"CV"-noun-0]|TX|4114/2;[3120/2],[3897/2]|
00000000|MMI|10.96|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-27-"follow-up"-adj-0,"FOLLOW-UP"-tx-26-"Follow-up"-adj-0,"FOLLOW-UP"-tx-3-"FOLLOW UP"-adj-0]|TX|4775/9;4723/9;1171/9|
00000000|MMI|10.96|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-27-"follow-up"-adj-0,"Follow-Up"-tx-26-"Follow-up"-adj-0,"Follow-Up"-tx-3-"FOLLOW UP"-adj-0]|TX|4775/9;4723/9;1171/9|
00000000|MMI|10.96|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-27-"follow-up"-adj-0,"Follow-up"-tx-26-"Follow-up"-adj-0,"Follow-up"-tx-3-"FOLLOW UP"-adj-0]|TX|4775/9;4723/9;1171/9|
00000000|MMI|10.96|follow-up|C1522577|[hlca]|["Follow Up"-tx-27-"follow-up"-adj-0,"Follow Up"-tx-26-"Follow-up"-adj-0,"Follow Up"-tx-3-"FOLLOW UP"-adj-0]|TX|4775/9;4723/9;1171/9|
00000000|MMI|10.86|Mild (qualifier value)|C2945599|[qlco]|["MILD"-tx-14-"mild"-adj-0,"Mildly"-tx-14-"mildly"-adv-0]|TX|[3039/4],[3517/4];3547/6|
00000000|MMI|10.69|Negative|C0205160|[qlco]|["Negative"-tx-14-"negative"-adj-0,"Negative"-tx-14-"negative"-noun-0,"Negative"-tx-13-"negative"-noun-0]|TX|[3421/8],[4013/8];[3421/8],[4013/8];2542/8|
00000000|MMI|10.69|Negative - answer|C3853545|[qlco]|["Negative"-tx-14-"negative"-adj-0,"Negative"-tx-14-"negative"-noun-0,"Negative"-tx-13-"negative"-noun-0]|TX|[3421/8],[4013/8];[3421/8],[4013/8];2542/8|
00000000|MMI|10.69|Negative Charge|C2825491|[qlco]|["Negative"-tx-14-"negative"-adj-0,"Negative"-tx-14-"negative"-noun-0,"Negative"-tx-13-"negative"-noun-0]|TX|[3421/8],[4013/8];[3421/8],[4013/8];2542/8|
00000000|MMI|10.69|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-14-"negative"-adj-0,"NEGATIVE"-tx-14-"negative"-noun-0,"NEGATIVE"-tx-13-"negative"-noun-0]|TX|[3421/8],[4013/8];[3421/8],[4013/8];2542/8|
00000000|MMI|10.69|Negative Number|C2825415|[cnce]|["Negative"-tx-14-"negative"-adj-0,"Negative"-tx-14-"negative"-noun-0,"Negative"-tx-13-"negative"-noun-0]|TX|[3421/8],[4013/8];[3421/8],[4013/8];2542/8|
00000000|MMI|10.60|Code|C0805701|[inpr]|["CODE"-tx-25-"CODE"-noun-0,"CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|4694/4;262/4;280/4|
00000000|MMI|10.60|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-25-"CODE"-noun-0,"Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|4694/4;262/4;280/4|
00000000|MMI|10.53|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-3-"MG"-noun-0]|TX|[356/2],[433/2],[1048/2]|
00000000|MMI|10.53|Milligram percent|C1960952|[qnco]|["mg %"-tx-3-"MG"-noun-0]|TX|[356/2],[433/2],[1048/2]|
00000000|MMI|10.53|mg/dL|C0439269|[qnco]|["mg%"-tx-3-"MG"-noun-0]|TX|[356/2],[433/2],[1048/2]|
00000000|MMI|10.51|10%|C3842590|[fndg]|["10%"-tx-14-"10"-integer-0,"10%"-tx-3-"10"-integer-0]|TX|2842/2;[504/2],[891/2]|
00000000|MMI|10.42|Approximate|C0332232|[qlco]|["Approximate"-tx-3-"approximate"-adj-0]|TX|[876/11],[950/11]|
00000000|MMI|10.42|Control function|C2587213|[ftcn]|["Controlled"-tx-21-"controlled"-verb-0,"Controlled"-tx-3-"Controlled"-verb-0]|TX|4557/10;1093/10|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1239/9],[1352/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1239/9],[1352/9]|
00000000|MMI|10.42|Disease Controlled|C2911690|[fndg]|["Controlled"-tx-21-"controlled"-verb-0,"Controlled"-tx-3-"Controlled"-verb-0]|TX|4557/10;1093/10|
00000000|MMI|10.42|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|589/3;257/3|
00000000|MMI|10.42|Osa <plant>|C1656862|[plnt]|["Osa"-tx-14-"OSA"-noun-0,"Osa"-tx-3-"OSA"-noun-0]|TX|2632/3;1489/3|
00000000|MMI|10.42|Patient need for (contextual qualifier)|C0686904|[ftcn]|["needed"-tx-19-"needed"-verb-0,"needed"-tx-17-"needed"-verb-0]|TX|4322/6;4253/6|
00000000|MMI|10.42|Requirement|C1514873|[ftcn]|["Required"-tx-3-"Required"-verb-0]|TX|[865/8],[939/8]|
00000000|MMI|10.42|To|C1883351|[qlco]|["To"-tx-17-"to"-adv-0,"To"-tx-8-"to"-adv-0]|TX|4206/2;2185/2|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-31-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5087/6;48/6|
00000000|MMI|9.94|Appointments|C0003629|[idcn]|["Appointment"-tx-3-"APPOINTMENT"-noun-0]|TX|1181/11|N04.452.095
00000000|MMI|9.86|Pressure- physical agent|C0033095|[phpr]|["Pressure"-tx-4-"pressure"-noun-0]|TX|1883/8|G01.374.715
00000000|MMI|9.78|Neonatal Abstinence Syndrome|C0027609|[dsyn]|["NAS"-tx-3-"NAS"-noun-0]|TX|1074/3|C16.614.610;C25.775.650;F03.900.650
00000000|MMI|9.76|Germany|C0017480|[geoa]|["DE"-tx-1-"De"-noun-0]|TX|87/2|Z01.542.315;Z01.586.315
00000000|MMI|9.75|Beds|C0004916|[mnob]|["Bed"-tx-14-"bed"-noun-0]|TX|3058/3|E07.325.220
00000000|MMI|9.74|Abdomen|C0000726|[blor]|["abd"-tx-14-"Abd"-noun-0]|TX|3183/3|A01.923.047
00000000|MMI|9.73|Historical aspects qualifier|C0019665|[ftcn]|["history"-tx-14-"history"-noun-0]|TX|3901/7|x.x.x
00000000|MMI|9.73|Anxiety|C0003467|[mobd]|["-- Anxiety"-tx-19-"anxiety"-noun-0]|TX|4367/7|F01.470.132
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1220/7|C20.543
00000000|MMI|8.34|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-3-"ALLERGY"-noun-0]|TX|1220/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-3-"Infections"-noun-0]|TX|1375/10|C01.539
00000000|MMI|8.34|Transdermal Patch|C0991556|[medd]|["Patch"-tx-3-"PATCH"-noun-0]|TX|764/5|E07.935
00000000|MMI|7.70|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-14-"CAD"-noun-0,"CAD"-tx-10-"CAD"-noun-0]|TX|2683/3;2321/3|
00000000|MMI|7.70|Clinical Trial Final Report|C3889645|[inpr]|["Reports"-tx-13-"reports"-verb-0,"Reports"-tx-8-"reports"-noun-0]|TX|2493/7;2109/7|
00000000|MMI|7.70|Dosage|C0178602|[qnco]|["DOSE"-tx-28-"dose"-noun-0,"Doses"-tx-3-"Doses"-noun-0]|TX|4866/4;859/5|
00000000|MMI|7.70|Report (document)|C0684224|[inpr]|["Reports"-tx-13-"reports"-verb-0,"Reports"-tx-8-"reports"-noun-0]|TX|2493/7;2109/7|
00000000|MMI|7.70|Reporting|C0700287|[hlca]|["reports"-tx-13-"reports"-verb-0,"reports"-tx-8-"reports"-noun-0]|TX|2493/7;2109/7|
00000000|MMI|7.61|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-29-"3"-integer-0,"3+"-tx-3-"3"-integer-0]|TX|4872/1;965/1|
00000000|MMI|7.61|3+ Score|C2827736|[qnco]|["3+"-tx-29-"3"-integer-0,"3+"-tx-3-"3"-integer-0]|TX|4872/1;965/1|
00000000|MMI|7.61|3+ Score, WHO|C2981702|[clas]|["3+"-tx-29-"3"-integer-0,"3+"-tx-3-"3"-integer-0]|TX|4872/1;965/1|
00000000|MMI|7.61|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-29-"3"-integer-0,"<3"-tx-3-"3"-integer-0]|TX|4872/1;965/1|
00000000|MMI|7.61|Carbohydrates|C0007004|[orch]|["CARBOHYDRATE"-tx-21-"Carbohydrate"-noun-0,"CARBOHYDRATE"-tx-3-"Carbohydrate"-noun-0]|TX|4544/12;1080/12|D09
00000000|MMI|7.53|Continuous|C0549178|[idcn]|["Continued"-tx-16-"continued"-verb-0,"Continued"-tx-15-"continued"-verb-0]|TX|4122/9;4043/9|
00000000|MMI|7.53|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-30-"Return"-noun-0,"Returned"-tx-7-"returned"-verb-0]|TX|4875/6;2032/8|
00000000|MMI|7.48|Condition|C0348080|[qlco]|["Condition"-tx-30-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|4949/9;1362/10|
00000000|MMI|7.48|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-30-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|4949/9;1362/10|
00000000|MMI|7.48|Logical Condition|C1705253|[cnce]|["Condition"-tx-30-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|4949/9;1362/10|
00000000|MMI|7.46|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-14-"pain"-noun-1,"Pain NOS"-tx-7-"pain"-noun-0]|TX|3163/4;2027/4|
00000000|MMI|7.40|Deficit|C2987487|[qlco]|["deficits"-tx-14-"deficits"-noun-0,"deficits"-tx-11-"deficits"-noun-0]|TX|3275/8;2439/8|
00000000|MMI|7.36|Encounter due to tobacco use|C0040335|[fndg]|["Tobacco use NOS"-tx-14-"tobacco use"-noun-0,"Tobacco use NOS"-tx-3-"tobacco use"-noun-0]|TX|2714/11;1723/11|
00000000|MMI|7.36|History of tobacco use|C0841002|[fndg]|["Tobacco use"-tx-14-"tobacco use"-noun-0,"Tobacco use"-tx-3-"tobacco use"-noun-0]|TX|2714/11;1723/11|
00000000|MMI|7.36|Tobacco user|C3853727|[fndg]|["Tobacco use"-tx-14-"tobacco use"-noun-0,"Tobacco use"-tx-3-"tobacco use"-noun-0]|TX|2714/11;1723/11|
00000000|MMI|7.35|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-16-"meds"-noun-0,"MEDS"-tx-14-"Meds"-noun-0]|TX|4117/4;2761/4|
00000000|MMI|7.33|Cardiac enzymes|C0443763|[aapp,enzy]|["Cardiac enzymes"-tx-14-"Cardiac Enzymes"-noun-0,"Cardiac enzymes"-tx-14-"cardiac enzymes"-noun-0]|TX|3396/15;3977/15|
00000000|MMI|7.32|6/3|C1630409|[fndg]|["6/3"-tx-31-"6/3"-fraction-0,"6/3"-tx-2-"6/3"-fraction-0]|TX|5045/3;129/3|
00000000|MMI|7.32|Basal Diet|C2983588|[food]|["DIET"-tx-21-"diet"-noun-0,"DIET"-tx-3-"DIET"-noun-0]|TX|4576/4;1060/4|
00000000|MMI|7.32|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-21-"diet"-noun-0,"Diet"-tx-3-"DIET"-noun-0]|TX|4576/4;1060/4|
00000000|MMI|7.32|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-21-"diet"-noun-0,"DIET"-tx-3-"DIET"-noun-0]|TX|4576/4;1060/4|
00000000|MMI|7.31|Pulmonary ventilator management|C1315068|[hlca]|["PULM"-tx-19-"pulm"-adj-0,"PULM"-tx-18-"Pulm"-adj-0]|TX|4304/4;4262/4|
00000000|MMI|7.31|BLOOD GROUP--WALDNER TYPE|C1862191|[fndg]|["WD"-tx-14-"wd"-noun-0]|TX|[2845/2],[2883/2]|
00000000|MMI|7.31|SLC4A1 wt Allele|C3538902|[gngm]|["WD"-tx-14-"wd"-noun-0]|TX|[2845/2],[2883/2]|
00000000|MMI|7.31|Working diagnosis|C0332135|[qlco]|["WD"-tx-14-"wd"-noun-0]|TX|[2845/2],[2883/2]|
00000000|MMI|7.29|80%|C3842583|[fndg]|["80%"-tx-14-"80"-fraction-0,"80%"-tx-14-"80"-integer-0]|TX|[2995/2],[3011/2];[2995/2],[3011/2]|
00000000|MMI|7.28|Clinical Trials, Monitoring|C1516647|[resa]|["monitoring"-tx-15-"monitoring"-noun-0,"monitoring"-tx-14-"monitoring"-noun-0]|TX|4032/10;3962/10|
00000000|MMI|7.28|Clinical act of insertion|C0441587|[hlca]|["Placement"-tx-14-"placement"-noun-0,"Placement"-tx-9-"placement"-noun-0]|TX|2613/9;2266/9|
00000000|MMI|7.28|Monitoring - action|C1283169|[hlca]|["Monitoring"-tx-15-"monitoring"-noun-0,"Monitoring"-tx-14-"monitoring"-noun-0]|TX|4032/10;3962/10|
00000000|MMI|7.28|Placement|C1524072|[qlco]|["Placement"-tx-14-"placement"-noun-0,"Placement"-tx-9-"placement"-noun-0]|TX|2613/9;2266/9|
00000000|MMI|7.28|Placement action|C1533810|[hlca]|["Placement"-tx-14-"placement"-noun-0,"Placement"-tx-9-"placement"-noun-0]|TX|2613/9;2266/9|
00000000|MMI|7.28|TCAP gene|C1420621|[gngm]|["TELE"-tx-15-"tele"-noun-0,"TELE"-tx-14-"tele"-noun-0]|TX|4027/4;3957/4|
00000000|MMI|7.28|Telephone Number|C1515258|[cnce]|["Tele"-tx-15-"tele"-noun-0,"Tele"-tx-14-"tele"-noun-0]|TX|4027/4;3957/4|
00000000|MMI|7.27|Hospital course|C0489547|[fndg]|["Hospital course"-tx-14-"Hospital Course"-noun-1,"Hospital course"-tx-3-"HOSPITAL COURSE"-noun-1]|TX|3879/15;1648/15|
00000000|MMI|7.27|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-14-"Hospital Course"-noun-0,"Hospital course"-tx-3-"HOSPITAL COURSE"-noun-0]|TX|3879/15;1648/15|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-30-"summary"-noun-0,"Summary"-tx-2-"SUMMARY"-noun-0]|TX|4991/7;213/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-30-"summary"-noun-0,"summary"-tx-2-"SUMMARY"-noun-0]|TX|4991/7;213/7|
00000000|MMI|7.25|Character String Data Type|C3272372|[inpr]|["ST"-tx-14-"ST"-noun-0,"ST"-tx-1-"St"-noun-0]|TX|3378/2;90/2|
00000000|MMI|7.25|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-28-"dose"-noun-0,"Dose number"-tx-3-"Number Doses"-noun-0]|TX|4866/4;923/6,933/5|
00000000|MMI|7.22|R prime|C2603358|[clna]|["R'"-tx-14-"r"-noun-0,"R'"-tx-3-"R"-noun-0]|TX|3143/1;1622/1|
00000000|MMI|7.22|Right|C0205090|[spco]|["R-"-tx-14-"r"-noun-0,"R-"-tx-3-"R"-noun-0]|TX|3143/1;1622/1|
00000000|MMI|7.22|Medical History|C0262926|[fndg]|["History"-tx-14-"history"-noun-1,"PMH"-tx-14-"PMH"-noun-0]|TX|3901/7;2590/3|
00000000|MMI|7.21|Chief complaint (finding)|C0277786|[fndg]|["complaints"-tx-19-"complaints"-noun-0,"complaints"-tx-3-"complaints"-noun-0]|TX|4397/10;1782/10|
00000000|MMI|7.21|Last|C1517741|[qlco]|["Last"-tx-11-"Last"-adj-0,"Last"-tx-7-"lasting"-verb-0]|TX|2349/4;2082/7|
00000000|MMI|7.19|CETRIMONIUM BROMIDE|C0951233|[hops,orch]|["CTAB"-tx-18-"ctab"-noun-0,"CTAB"-tx-14-"ctab"-noun-0]|TX|4287/4;3115/4|
00000000|MMI|7.18|Negation|C1518422|[ftcn]|["Not"-tx-10-"not"-adv-0,"Not"-tx-3-"NOT"-adv-0]|TX|2327/3;1613/3|
00000000|MMI|7.18|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-10-"PUO"-noun-1,"puo"-tx-8-"PUO"-noun-0]|TX|2334/3;2201/3|
00000000|MMI|7.13|Ambulate|C4036205|[fndg]|["Ambulate"-tx-11-"ambulated"-verb-0,"Ambulate"-tx-4-"ambulating"-verb-0]|TX|2375/9;1813/10|
00000000|MMI|7.13|Stair (equipment)|C2825408|[mnob]|["Stair"-tx-8-"stairs"-noun-0,"Stair"-tx-4-"stairs"-noun-0]|TX|2134/6;1827/6|
00000000|MMI|7.13|Staircase|C1710179|[geoa]|["Stair"-tx-8-"stairs"-noun-0,"Stair"-tx-4-"stairs"-noun-0]|TX|2134/6;1827/6|
00000000|MMI|7.07|Intervention regimes|C1273869|[hlca]|["Intervention"-tx-19-"intervention"-noun-0,"Interventions"-tx-17-"interventions"-noun-0]|TX|4309/12;4239/13|
00000000|MMI|7.07|Nursing interventions|C0886296|[hlca]|["intervention"-tx-19-"intervention"-noun-0,"interventions"-tx-17-"interventions"-noun-0]|TX|4309/12;4239/13|
00000000|MMI|7.06|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-30-"Stable"-adj-0,"Stable"-tx-17-"stable"-adj-0]|TX|4960/6;4224/6|
00000000|MMI|7.06|Stable status|C0205360|[qlco]|["STABLE"-tx-30-"Stable"-adj-0,"STABLE"-tx-17-"stable"-adj-0]|TX|4960/6;4224/6|
00000000|MMI|7.05|PACERR gene|C3890506|[gngm]|["PACER"-tx-27-"pacer"-noun-0,"PACER"-tx-17-"pacer"-noun-0]|TX|4769/5;4216/5|
00000000|MMI|7.04|55|C0450382|[inpr]|["55"-tx-14-"55"-percentage-0,"55"-tx-12-"55"-percentage-0]|TX|3461/2;2463/2|
00000000|MMI|7.04|mg/mg|C1319635|[qnco]|["mg/mg"-tx-3-"MG MG"-noun-0]|TX|[476/2,507/2],[985/2,1007/2]|
00000000|MMI|7.02|Echo (insect)|C1655045|[euka]|["Echo"-tx-15-"ECHO"-noun-0,"Echo"-tx-14-"ECHO"-noun-0]|TX|4059/4;3430/4|
00000000|MMI|7.01|Discontinued|C1444662|[fndg]|["D/C"-tx-24-"d/c"-noun-0,"D/C"-tx-2-"D/C"-noun-1]|TX|4626/3;184/3|
00000000|MMI|7.01|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-24-"d/c"-noun-0,"D.C."-tx-2-"D/C"-noun-0]|TX|4626/3;184/3|
00000000|MMI|7.00|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-21-"cardiac"-adj-0,"Cardiac"-tx-3-"cardiac"-adj-0]|TX|4568/7;1690/7|
00000000|MMI|6.98|Biomedical Monitors|C0181904|[medd]|["Monitor"-tx-28-"Monitor"-noun-0,"Monitor"-tx-23-"Monitored"-adj-0]|TX|4799/7;4599/9|
00000000|MMI|6.98|Monitor Device Component|C1704646|[mnob]|["Monitor"-tx-28-"Monitor"-noun-0,"Monitor"-tx-23-"Monitored"-adj-0]|TX|4799/7;4599/9|
00000000|MMI|6.98|Monitor, occupation|C1521743|[prog]|["Monitor"-tx-28-"Monitor"-noun-0,"Monitor"-tx-23-"Monitored"-adj-0]|TX|4799/7;4599/9|
00000000|MMI|6.98|Monitoring Device|C0596972|[medd]|["Monitor"-tx-28-"Monitor"-noun-0,"Monitor"-tx-23-"Monitored"-adj-0]|TX|4799/7;4599/9|
00000000|MMI|6.97|Full|C0443225|[qlco]|["Full"-tx-25-"FULL"-adj-0,"Full"-tx-3-"Full"-adj-0]|TX|4689/4;275/4|
00000000|MMI|6.97|Gram per Deciliter|C0439267|[qnco]|["g%"-tx-14-"G"-noun-0,"g%"-tx-14-"g"-adj-0]|TX|3227/1;3141/1|
00000000|MMI|6.94|Baseline|C1442488|[qnco]|["Baseline"-tx-24-"baseline"-noun-0,"Baseline"-tx-16-"Baseline"-noun-0]|TX|4638/8;4105/8|
00000000|MMI|6.94|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-3-"Dr"-noun-0]|TX|4738/2;1199/2|
00000000|MMI|6.94|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-3-"Dr"-noun-0]|TX|4738/2;1199/2|
00000000|MMI|6.94|Doctor - Title|C2348314|[cnce]|["Dr."-tx-26-"Dr"-noun-0,"Dr."-tx-3-"Dr"-noun-0]|TX|4738/2;1199/2|
00000000|MMI|6.88|Gait normal|C0231683|[fndg]|["Normal"-tx-14-"Normal"-adj-0,"Normal"-tx-14-"normal"-adj-1]|TX|3440/6;3634/6|
00000000|MMI|6.88|Mean Percent of Normal|C2347086|[qnco]|["% Normal"-tx-14-"Normal"-adj-0,"% Normal"-tx-14-"normal"-adj-0]|TX|3440/6;3634/6|
00000000|MMI|6.88|Percent normal|C0439166|[qnco]|["% normal"-tx-14-"Normal"-adj-0,"% normal"-tx-14-"normal"-adj-0]|TX|3440/6;3634/6|
00000000|MMI|6.83|Lung|C0024109|[bpoc]|["LUNGS"-tx-14-"Lungs"-noun-0]|TX|3108/5|A04.411
00000000|MMI|6.75|Periodicals|C0031082|[inpr]|["serial"-tx-14-"serial"-adj-0]|TX|3993/6|V02.690
00000000|MMI|6.58|History|C0019664|[ocdi]|["History"-tx-14-"history"-noun-0]|TX|3901/7|K01.400
00000000|MMI|6.58|Anxiety Disorders|C0003469|[mobd]|["Anxiety"-tx-19-"anxiety"-noun-0]|TX|4367/7|F03.080
00000000|MMI|5.18|1+|C3816745|[fndg]|["1+"-tx-25-"1"-integer-0]|TX|4720/1|
00000000|MMI|5.18|1+ Score|C2827734|[qnco]|["1+"-tx-25-"1"-integer-0]|TX|4720/1|
00000000|MMI|5.18|1+ Score, WHO|C2981698|[clas]|["1+"-tx-25-"1"-integer-0]|TX|4720/1|
00000000|MMI|5.18|Acetaminophen [EPC]|C2917659|[phsu]|["Acetaminophen"-tx-3-"ACETAMINOPHEN"-noun-0]|TX|336/13|
00000000|MMI|5.18|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-2-"Service"-noun-0]|TX|94/7|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-3-"affecting"-verb-0]|TX|1404/9|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1220/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1220/7|
00000000|MMI|5.18|Ampere per Meter|C2346751|[qnco]|["A/m"-tx-15-"a.m"-noun-0]|TX|4080/3|
00000000|MMI|5.18|Assessed|C1516048|[acty]|["Assess"-tx-17-"assess"-verb-0]|TX|4209/6|
00000000|MMI|5.18|Body tissue patch material|C1533128|[bodm]|["Patch"-tx-3-"PATCH"-noun-0]|TX|764/5|
00000000|MMI|5.18|C-Circle|C3538933|[celc]|["CC"-tx-3-"cc"-noun-0]|TX|1665/2|
00000000|MMI|5.18|Changed status|C0443172|[qnco]|["changes"-tx-14-"changes"-verb-0]|TX|3388/7|
00000000|MMI|5.18|Changing|C0392747|[ftcn]|["changes"-tx-14-"changes"-verb-0]|TX|3388/7|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-3-"Complications"-noun-0]|TX|1388/13|
00000000|MMI|5.18|Data|C1511726|[idcn]|["Data"-tx-14-"Data"-noun-0]|TX|3289/4|
00000000|MMI|5.18|Data (eukaryote)|C3714741|[euka]|["Data"-tx-14-"Data"-noun-0]|TX|3289/4|
00000000|MMI|5.18|Data call receiving device|C3245479|[medd]|["data"-tx-14-"Data"-noun-0]|TX|3289/4|
00000000|MMI|5.18|Delta (difference)|C1705241|[qnco]|["Change"-tx-14-"changes"-verb-0]|TX|3388/7|
00000000|MMI|5.18|Depressed mood|C0344315|[fndg]|["depression"-tx-3-"depression"-noun-0]|TX|1449/10|
00000000|MMI|5.18|Depression Scale (BASC-2)|C4049644|[inpr]|["Depression"-tx-3-"depression"-noun-0]|TX|1449/10|
00000000|MMI|5.18|Depression motion|C0460137|[ftcn]|["Depression"-tx-3-"depression"-noun-0]|TX|1449/10|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-14-"edema"-noun-0]|TX|3243/5|
00000000|MMI|5.18|Entire aortic valve|C1269005|[bpoc]|["Aortic valve"-tx-14-"aortic valve"-noun-0]|TX|3534/12|
00000000|MMI|5.18|Entire left upper arm|C1268256|[bpoc]|["Left arm"-tx-4-"left arm"-noun-0]|TX|1905/8|
00000000|MMI|5.18|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-6-"given"-verb-0]|TX|2005/5|
00000000|MMI|5.18|Experience|C0596545|[menp]|["Experience"-tx-30-"experience"-verb-0]|TX|4895/10|
00000000|MMI|5.18|GIVEN|C1442162|[cnce]|["GIVEN"-tx-6-"given"-verb-0]|TX|2005/5|
00000000|MMI|5.18|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-6-"given"-verb-0]|TX|2005/5|
00000000|MMI|5.18|Given name|C3244317|[inpr]|["given"-tx-6-"given"-verb-0]|TX|2005/5|
00000000|MMI|5.18|Human patch material|C0445403|[bodm]|["Patch"-tx-3-"PATCH"-noun-0]|TX|764/5|
00000000|MMI|5.18|Including (qualifier)|C0332257|[ftcn]|["Including"-tx-3-"including"-verb-0]|TX|1713/9|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-3-"PROCEDURES"-noun-0]|TX|1566/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-3-"affecting"-verb-0]|TX|1404/9|
00000000|MMI|5.18|Jugular venous engorgement|C0425687|[fndg]|["JVD"-tx-14-"JVD"-noun-1]|TX|3080/3|
00000000|MMI|5.18|Left upper arm structure|C0230347|[bpoc]|["Left Arm"-tx-4-"left arm"-noun-0]|TX|1905/8|
00000000|MMI|5.18|MANEA gene|C1427293|[gngm]|["ENDO"-tx-20-"Endo"-adj-0]|TX|4410/4|
00000000|MMI|5.18|MILDLY|C0750532|[idcn]|["MILDLY"-tx-14-"mildly"-adv-0]|TX|3547/6|
00000000|MMI|5.18|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-2-"Not Applicable"-adj-0]|TX|164/14|
00000000|MMI|5.18|Old|C0580836|[tmco]|["Old"-tx-14-"OLD"-noun-0]|TX|3335/3|
00000000|MMI|5.18|On admission|C0457453|[tmco]|["On admission"-tx-14-"on Admission"-adj-0]|TX|2963/12|
00000000|MMI|5.18|PPP4C gene|C1418850|[gngm]|["PPX"-tx-25-"PPx"-noun-0]|TX|4667/3|
00000000|MMI|5.18|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-2-"Not Applicable"-adj-0]|TX|164/14|
00000000|MMI|5.18|Pairing Events Domain|C3541314|[inpr]|["PA"-tx-31-"PA"-noun-0]|TX|5033/2|
00000000|MMI|5.18|Patch - Extended Release Film|C1707974|[bodm]|["PATCH"-tx-3-"PATCH"-noun-0]|TX|764/5|
00000000|MMI|5.18|Patch Dosing Unit|C1706366|[qnco]|["{Patch}"-tx-3-"PATCH"-noun-0]|TX|764/5|
00000000|MMI|5.18|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-30-"worsening"-verb-0]|TX|4906/9|
00000000|MMI|5.18|Pericardial effusion body substance|C1253937|[bdsu]|["Pericardial effusion"-tx-14-"pericardial effusion"-noun-0]|TX|3853/20|
00000000|MMI|5.18|Plaque (lesion)|C0332461|[fndg]|["Patch"-tx-3-"PATCH"-noun-0]|TX|764/5|
00000000|MMI|5.18|Practice Experience|C0237607|[menp]|["experience"-tx-30-"experience"-verb-0]|TX|4895/10|
00000000|MMI|5.18|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-19-"likely"-adv-0]|TX|4375/6|
00000000|MMI|5.18|Probably|C0750492|[idcn]|["Likely"-tx-19-"likely"-adv-0]|TX|4375/6|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1566/10|
00000000|MMI|5.18|Prompting|C0871157|[ftcn]|["prompted"-tx-8-"prompted"-verb-0]|TX|2172/8|
00000000|MMI|5.18|Pupil equal round and reacting to light|C1642390|[fndg]|["PERRL"-tx-14-"PERRL"-noun-1]|TX|3095/5|
00000000|MMI|5.18|Quantity Final Containers Returned|C3714905|[qnco]|["Returned"-tx-7-"returned"-verb-0]|TX|2032/8|
00000000|MMI|5.18|Regulatory Report|C3273238|[inpr]|["Report"-tx-13-"reports"-verb-0]|TX|2493/7|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-3-"ALLERGY"-noun-0]|TX|1220/7|
00000000|MMI|5.18|Retinol Activity Equivalent|C1882947|[qnco]|["RAE"-tx-14-"RAE"-noun-0]|TX|3528/3|
00000000|MMI|5.18|Revealed|C0443289|[qlco]|["Revealed"-tx-10-"revealed"-verb-0]|TX|2297/8|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-3-"("-noun-0]|TX|1192/1|
00000000|MMI|5.18|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-14-"soft"-adj-1]|TX|3203/4|
00000000|MMI|5.18|Services|C0557854|[ocac]|["Service"-tx-2-"Service"-noun-0]|TX|94/7|
00000000|MMI|5.18|Set scale|C1442518|[ftcn]|["Set"-tx-14-"sets"-verb-0]|TX|3416/4|
00000000|MMI|5.18|Soft|C0205358|[qlco]|["Soft"-tx-14-"soft"-adj-0]|TX|3203/4|
00000000|MMI|5.18|Software Service|C2825316|[mnob]|["Service"-tx-2-"Service"-noun-0]|TX|94/7|
00000000|MMI|5.18|Surgical patch|C1305400|[medd]|["Patch"-tx-3-"PATCH"-noun-0]|TX|764/5|
00000000|MMI|5.18|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-3-"NKA"-noun-0]|TX|1229/3|
00000000|MMI|5.18|Thickened|C0205400|[fndg]|["Thickened"-tx-14-"thickened"-verb-0]|TX|3554/9|
00000000|MMI|5.18|Worse|C1457868|[fndg]|["Worsening"-tx-30-"worsening"-verb-0]|TX|4906/9|
00000000|MMI|5.18|Worsening pattern|C0332271|[qlco]|["Worsening"-tx-30-"worsening"-verb-0]|TX|4906/9|
00000000|MMI|5.18|gastritis h pylori|C0744310|[dsyn]|["gastritis h pylori"-tx-14-"gastritis H pylori"-noun-0]|TX|2689/9,2700/1,2703/6|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-3-"("-noun-0]|TX|1192/1|
00000000|MMI|5.18|set (group)|C1705195|[cnce]|["Set"-tx-14-"sets"-verb-0]|TX|3416/4|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-3-"TREATMENTS/PROCEDURES"-noun-0]|TX|1589/21|
00000000|MMI|5.18|tricuspid regurgitation trace|C0749690|[dsyn]|["trace tricuspid regurgitation"-tx-14-"trace tricuspid regurgitation"-noun-1]|TX|3695/29|
00000000|MMI|4.12|Electrocardiographic changes|C0855329|[fndg]|["ekg change"-tx-11-"EKG changes"-noun-1]|TX|2411/11|
00000000|MMI|3.78|Regional congenital anomaly|C0266641|[cgab]|["Regional Abnormalities"-tx-14-"regional abnormalities"-noun-1]|TX|3470/8,3484/13|
00000000|MMI|3.76|MR vaccine|C0694746|[imft,phsu]|["M/R"-tx-14-"m r"-noun-0]|TX|3137/1,3143/1|
00000000|MMI|3.75|2 Days|C1442455|[tmco]|["2 Days"-tx-4-"2 days"-noun-0]|TX|1794/6|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-3-"DISCHARGE MEDICATIONS"-noun-0]|TX|303/21|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1253/9,1273/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1253/9,1273/9|
00000000|MMI|3.68|Inverted T wave|C0520888|[fndg]|["T Wave Inversion"-tx-14-"T wave inversion"-noun-0]|TX|3343/16|
00000000|MMI|3.68|ALYREF gene|C1425988|[gngm]|["REF"-tx-3-"ref"-noun-0]|TX|634/3|
00000000|MMI|3.68|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1551/10|
00000000|MMI|3.68|Admission activity|C0809949|[hlca]|["Admission"-tx-3-"Admission"-noun-0]|TX|1320/9|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-2-"Attending"-noun-0]|TX|226/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-2-"Attending"-noun-0]|TX|226/9|
00000000|MMI|3.68|Coating (film)|C1522408|[qlco]|["Coated"-tx-3-"COATED"-adj-0]|TX|420/6|
00000000|MMI|3.68|Enteral|C1304890|[spco]|["Enteric"-tx-3-"ENTERIC"-adj-0]|TX|412/7|
00000000|MMI|3.68|GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO (finding)|C1847730|[fndg]|["NTG"-tx-6-"NTG"-noun-1]|TX|2001/3|
00000000|MMI|3.68|HEENT|C1512338|[blor]|["HEENT"-tx-14-"HEENT"-noun-0]|TX|3070/5|
00000000|MMI|3.68|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1551/10|
00000000|MMI|3.68|K Prime|C1708601|[qnco]|["K'"-tx-30-"K"-noun-0]|TX|5028/1|
00000000|MMI|3.68|LBP protein, human|C1505993|[aapp,bacs]|["LBP"-tx-14-"LBP"-noun-0]|TX|2747/3|
00000000|MMI|3.68|Left atrial hypertrophy|C0238705|[anab]|["LAE"-tx-14-"LAE"-noun-1]|TX|3522/3|
00000000|MMI|3.68|OPA1 gene|C1417953|[gngm]|["NTG"-tx-6-"NTG"-noun-0]|TX|2001/3|
00000000|MMI|3.68|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-30-"K"-noun-0]|TX|5028/1|
00000000|MMI|3.68|SS, Rat Strain|C2699257|[mamm]|["SS"-tx-20-"SS"-noun-0]|TX|4540/2|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|267/6|
00000000|MMI|3.68|Subject Status Domain|C3891295|[inpr]|["SS"-tx-20-"SS"-noun-0]|TX|4540/2|
00000000|MMI|3.68|T wave feature|C0429103|[fndg]|["T wave"-tx-14-"T wave"-noun-1]|TX|3381/6|
00000000|MMI|3.68|Unit dose|C0869039|[qnco]|["Dose"-tx-28-"dose"-noun-0]|TX|4866/4|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-3-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1263/19|
00000000|MMI|3.65|risk factors - observation list|C1553898|[inpr]|["risk factors"-tx-3-"risk factors"-noun-0]|TX|1698/12|
00000000|MMI|3.64|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-20-"held"-verb-0]|TX|4461/4|
00000000|MMI|3.64|Associated with|C0332281|[qlco]|["Associated with"-tx-5-"Associated with"-verb-0]|TX|1915/15|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-30-"ENTERED"-verb-0]|TX|4999/7|
00000000|MMI|3.64|Held - activity status|C1948036|[idcn]|["held"-tx-20-"held"-verb-0]|TX|4461/4|
00000000|MMI|3.63|4+ Answer to question|C3838679|[fndg]|["4+"-tx-1-"4"-fraction-0]|TX|16/1|
00000000|MMI|3.63|Additional comments|C1830770|[fndg]|["Additional comments"-tx-25-"ADDITIONAL COMMENTS"-noun-0]|TX|4699/19|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|285/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|285/11|
00000000|MMI|3.63|HP gene|C1415692|[gngm]|["Bp"-tx-14-"BP"-noun-0]|TX|3004/2|
00000000|MMI|3.63|HP wt Allele|C1708288|[gngm]|["BP"-tx-14-"BP"-noun-0]|TX|3004/2|
00000000|MMI|3.63|Interaction|C1704675|[ftcn]|["Interaction"-tx-3-"INTERACTION"-noun-0]|TX|672/11|
00000000|MMI|3.63|O NOS Ab|C0483204|[aapp,imft]|["O NOS"-tx-14-"O"-noun-0]|TX|3258/1|
00000000|MMI|3.63|Surgical and medical procedures|C1948041|[topp]|["Intervention"-tx-19-"intervention"-noun-0]|TX|4309/12|
00000000|MMI|3.63|aspirin enteric coated|C0718690|[orch,phsu]|["enteric coated aspirin"-tx-3-"ENTERIC COATED ASPIRIN"-noun-0]|TX|379/22|
00000000|MMI|3.62|1-2 days|C3843197|[fndg]|["1-2 days"-tx-13-"1-2 days"-noun-0]|TX|2501/8|
00000000|MMI|3.61|Apyrexial|C0277797|[fndg]|["Afebrile"-tx-14-"Afebrile"-adj-0]|TX|2981/8|
00000000|MMI|3.61|GEN1 gene|C2239486|[gngm]|["Gen"-tx-14-"Gen"-noun-0]|TX|3028/3|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-30-"PLAN"-noun-0]|TX|4973/4|
00000000|MMI|3.61|Posterior segmental vein|C0507237|[bpoc]|["V2"-tx-14-"V2"-noun-0]|TX|3330/2|
00000000|MMI|3.61|Sugars|C0242209|[orch,phsu]|["Sugars"-tx-28-"sugars"-noun-0]|TX|4820/6|D09
00000000|MMI|3.61|TRGV9 gene|C1421140|[gngm]|["V2"-tx-14-"V2"-noun-0]|TX|3330/2|
00000000|MMI|3.61|Tee Device Component|C1710361|[mnob]|["Tee"-tx-12-"TEE"-noun-0]|TX|2449/3|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-30-"PLAN"-noun-0]|TX|4973/4|
00000000|MMI|3.61|V2 stage|C0457423|[fndg]|["V2"-tx-14-"V2"-noun-1]|TX|3330/2|
00000000|MMI|3.60|Maxillary right third molar mesial prosthesis|C1552211|[medd]|["1pm"-tx-3-"1pm"-noun-0]|TX|1214/3|
00000000|MMI|3.60|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|Active|C0205177|[ftcn]|["Activity"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|Activities|C0441655|[acty]|["ACTIVITY"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|Percent Activity|C0439167|[qnco]|["% Activity"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-3-"ACTIVITY"-noun-0]|TX|1140/8|
00000000|MMI|3.60|Routine|C0205547|[qlco]|["Routine"-tx-27-"routine"-adj-0]|TX|4761/7|
00000000|MMI|3.59|Serial Number|C2348188|[inpr]|["SERIAL"-tx-14-"serial"-adj-0]|TX|3993/6|
00000000|MMI|3.59|event cycle|C1511572|[tmco]|["Cycles"-tx-14-"cycles"-noun-0]|TX|4004/6|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-31-"END"-noun-0]|TX|5070/3|
00000000|MMI|3.59|Experimental Result|C2825142|[fndg]|["Result"-tx-16-"result"-noun-0]|TX|4087/6|
00000000|MMI|3.59|Left|C0205091|[spco]|["left sided"-tx-4-"left sided"-adj-0]|TX|1872/10|
00000000|MMI|3.59|Left sided|C0443246|[spco]|["Left sided"-tx-4-"left sided"-adj-0]|TX|1872/10|
00000000|MMI|3.59|Record - QueryRequestLimit|C3853788|[qnco]|["record"-tx-28-"record"-noun-0]|TX|4831/6|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-3-"Responsible"-adj-0]|TX|1284/11|
00000000|MMI|3.59|Result|C1274040|[ftcn]|["Result"-tx-16-"result"-noun-0]|TX|4087/6|
00000000|MMI|3.59|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-6-"sat"-noun-0]|TX|1944/3|
00000000|MMI|3.59|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-6-"sat"-noun-0]|TX|1944/3|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-31-"END"-noun-0]|TX|5070/3|
00000000|MMI|3.59|What subject filter - Result|C1546471|[idcn]|["Result"-tx-16-"result"-noun-0]|TX|4087/6|
00000000|MMI|3.58|Count of entities|C0449788|[qnco]|["Number"-tx-3-"Number"-noun-0]|TX|849/6|
00000000|MMI|3.58|Numbers|C0237753|[qnco]|["*Number"-tx-3-"Number"-noun-0]|TX|849/6|
00000000|MMI|3.57|23|C0450348|[qnco]|["23"-tx-15-"23"-fraction-0]|TX|4074/2|
00000000|MMI|3.57|ALPP gene|C1412365|[gngm]|["PALP"-tx-5-"palp"-noun-0]|TX|1935/4|
00000000|MMI|3.57|ALPP wt Allele|C3812647|[gngm]|["PALP"-tx-5-"palp"-noun-0]|TX|1935/4|
00000000|MMI|3.57|Actual Discomfort|C2364135|[sosy]|["Discomfort"-tx-14-"discomfort"-noun-0]|TX|3044/10|
00000000|MMI|3.57|Clinical trial protocol document|C1507394|[inpr]|["Protocol"-tx-20-"protocol"-noun-0]|TX|4492/8|
00000000|MMI|3.57|Conditional|C1701901|[qlco]|["Contingent"-tx-2-"CONTINGENT"-noun-0]|TX|148/10|
00000000|MMI|3.57|Done (qualifier value)|C1272695|[qlco]|["Done"-tx-15-"done"-aux-0]|TX|4064/4|
00000000|MMI|3.57|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-8-"ED"-noun-0]|TX|2205/2|
00000000|MMI|3.57|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-3-"Reason"-noun-0]|TX|728/6|
00000000|MMI|3.57|Library Protocol|C1522729|[inpr]|["Protocol"-tx-20-"protocol"-noun-0]|TX|4492/8|
00000000|MMI|3.57|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-20-"DM"-noun-0]|TX|4489/2|
00000000|MMI|3.57|Malaise|C0231218|[sosy]|["DISCOMFORT"-tx-14-"discomfort"-noun-0]|TX|3044/10|
00000000|MMI|3.57|Palp - CHV concept|C2945620|[cnce]|["palp"-tx-5-"palp"-noun-0]|TX|1935/4|
00000000|MMI|3.57|Presentation|C0449450|[idcn]|["Presented"-tx-8-"presented"-verb-0]|TX|2188/9|
00000000|MMI|3.57|Protocol - answer to question|C3715209|[fndg]|["Protocol"-tx-20-"protocol"-noun-0]|TX|4492/8|
00000000|MMI|3.57|Protocols documentation|C0442711|[inpr]|["Protocol"-tx-20-"protocol"-noun-0]|TX|4492/8|
00000000|MMI|3.57|Quantity limited request - Records|C1548330|[idcn]|["Records"-tx-10-"records"-noun-0]|TX|2338/7|
00000000|MMI|3.57|Query Quantity Unit - Records|C1553414|[qlco]|["Records"-tx-10-"records"-noun-0]|TX|2338/7|
00000000|MMI|3.57|Related personal status|C0445223|[fndg]|["Related"-tx-19-"related"-verb-0]|TX|4382/7|
00000000|MMI|3.57|Relationships|C0439849|[qlco]|["Related"-tx-19-"related"-verb-0]|TX|4382/7|
00000000|MMI|3.57|Started|C1272689|[qlco]|["Started"-tx-14-"started"-verb-0]|TX|3946/7|
00000000|MMI|3.57|Study Protocol|C2348563|[inpr]|["Protocol"-tx-20-"protocol"-noun-0]|TX|4492/8|
00000000|MMI|3.57|put - instruction imperative|C1882509|[acty]|["Put"-tx-20-"put"-verb-0]|TX|4482/3|
00000000|MMI|3.56|Additional|C1524062|[ftcn]|["Added"-tx-3-"added"-verb-0]|TX|545/5|
00000000|MMI|3.55|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-3-"RESUME"-noun-0]|TX|1638/6|
00000000|MMI|3.55|Pressure (finding)|C0460139|[fndg]|["Pressure"-tx-4-"pressure"-noun-0]|TX|1883/8|
00000000|MMI|3.55|Pressure - action|C1306345|[ftcn]|["Pressure"-tx-4-"pressure"-noun-0]|TX|1883/8|
00000000|MMI|3.55|Radiating to|C0332301|[ftcn]|["radiating"-tx-4-"radiating"-noun-0]|TX|1892/9|
00000000|MMI|3.55|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-3-"RESUME"-noun-0]|TX|1638/6|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-2-"USED"-verb-1]|TX|197/4|
00000000|MMI|3.55|described|C1552738|[idcn]|["described"-tx-4-"described"-verb-0]|TX|1859/9|
00000000|MMI|3.55|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-3-"RESUME"-noun-0]|TX|1638/6|
00000000|MMI|3.54|Dose number|C1115464|[qnco]|["Dose number"-tx-3-"Number Doses"-noun-0]|TX|923/6,933/5|
00000000|MMI|3.53|Exercise Pain Management|C1522704|[topp]|["Exercise"-tx-7-"exercising"-noun-0]|TX|2049/10|
00000000|MMI|3.52|Concern|C2699424|[idcn]|["Concern"-tx-14-"concerning"-noun-0]|TX|3909/10|
00000000|MMI|3.51|Low cholesterol|C0860920|[fndg]|["Low cholesterol"-tx-3-"Low cholesterol"-adj-0]|TX|1106/3,1128/11|
00000000|MMI|3.51|Oxygen saturation:Substance Fraction:Point in time:Heart.atrium.right:Quantitative|C0488771|[clna]|["SaO2 % RA"-tx-14-"SaO2 RA"-noun-0]|TX|3016/4,3025/2|
00000000|MMI|3.51|g.m|C0456715|[qnco]|["m g"-tx-14-"m g"-noun-0]|TX|3137/1,3141/1|
00000000|MMI|3.50|Atypical|C0205182|[qlco]|["Atypical"-tx-3-"atypical"-adj-0]|TX|1332/8|
00000000|MMI|3.50|Biospecimen Domain|C3814390|[inpr]|["BS"-tx-18-"BS"-noun-0]|TX|4284/2|
00000000|MMI|3.50|Black Swiss Mouse|C4049076|[mamm]|["BS"-tx-18-"BS"-noun-0]|TX|4284/2|
00000000|MMI|3.50|Bug Search Subtest (WPPSI-IV)|C4050217|[inpr]|["BS"-tx-18-"BS"-noun-0]|TX|4284/2|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-3-"Causing"-adj-0]|TX|1312/7|
00000000|MMI|3.50|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.50|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.50|Fentanyl Transdermal Patch|C1251700|[clnd]|["Fentanyl Patch"-tx-14-"fentanyl patch"-noun-0]|TX|2899/14|
00000000|MMI|3.50|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.50|Finger-prick sampling (procedure)|C0457575|[diap]|["Finger Stick"-tx-28-"finger stick"-noun-0]|TX|4807/12|
00000000|MMI|3.50|Focal|C0205234|[spco]|["FOCAL"-tx-14-"focal"-adj-0]|TX|3269/5|
00000000|MMI|3.50|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-14-"NSR"-noun-0]|TX|3300/3|
00000000|MMI|3.50|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-14-"NSR"-noun-1]|TX|3300/3|
00000000|MMI|3.50|Non-obstructive|C0205304|[ftcn]|["Non-obstructive"-tx-10-"nonobstructive"-adj-0]|TX|2306/14|
00000000|MMI|3.50|ST segment elevation (finding)|C0520886|[fndg]|["ST ELEVATION"-tx-14-"ST elevation"-noun-1]|TX|3314/12|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-2-"YES"-noun-0]|TX|222/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-2-"YES"-noun-0]|TX|222/3|
00000000|MMI|3.50|atypia morphology|C0741302|[fndg]|["Atypical"-tx-3-"atypical"-adj-0]|TX|1332/8|
00000000|MMI|3.50|chronic|C0205191|[tmco]|["CHRONIC"-tx-14-"chronic"-adj-0]|TX|2739/7|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-30-"dictated"-adj-0]|TX|4982/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-30-"dictated"-adj-0]|TX|4982/8|
00000000|MMI|3.49|Supraaortic valve area structure|C0549113|[bpoc]|["Aortic root"-tx-14-"aortic root"-noun-0]|TX|3752/6,3766/4|
00000000|MMI|3.48|90%|C3842582|[fndg]|["90%"-tx-11-"90"-integer-0]|TX|2399/2|
00000000|MMI|3.48|<90|C0439087|[qnco]|["<90"-tx-11-"90"-integer-0]|TX|2399/2|
00000000|MMI|3.48|>90|C0439083|[qnco]|[">90"-tx-11-"90"-integer-0]|TX|2399/2|
00000000|MMI|3.48|Administration procedure|C1533734|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1414/9|
00000000|MMI|3.48|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-14-"asa"-noun-0]|TX|2786/3|
00000000|MMI|3.48|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1414/9|
00000000|MMI|3.48|Further|C1517331|[spco]|["Further"-tx-19-"further"-adj-0]|TX|4296/7|
00000000|MMI|3.48|House (environment)|C2003847|[mnob]|["House"-tx-3-"House"-noun-0]|TX|1066/5|
00000000|MMI|3.48|Minimum|C1524031|[qlco]|["Trace"-tx-14-"trace"-noun-0]|TX|3592/5|
00000000|MMI|3.48|Nausea and vomiting|C0027498|[sosy]|["Nausea/vomiting"-tx-30-"Nausea/Vomiting"-noun-0]|TX|4923/15|
00000000|MMI|3.48|Saturated fat|C0597423|[food,orch]|["Saturated fat"-tx-3-"saturated fat"-noun-0]|TX|1110/13|
00000000|MMI|3.48|Sequence Chromatogram|C1883002|[ftcn]|["Trace"-tx-14-"trace"-noun-0]|TX|3592/5|
00000000|MMI|3.48|Serious|C0205404|[qlco]|["Serious"-tx-3-"SERIOUS"-adj-0]|TX|664/7|
00000000|MMI|3.48|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1414/9|E02
00000000|MMI|3.48|Treating|C1522326|[ftcn]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1414/9|
00000000|MMI|3.48|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-3-"Treatment"-noun-0]|TX|1414/9|
00000000|MMI|3.48|Walls of a building|C0677535|[mnob]|["Wall"-tx-14-"wall"-noun-0]|TX|3479/4|
00000000|MMI|3.48|trace amount|C0442822|[qnco]|["Trace"-tx-14-"trace"-noun-0]|TX|3592/5|
00000000|MMI|3.48|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1414/9|
00000000|MMI|3.47|pulmonary artery.main|C0489875|[bpoc]|["artery main pulmonary"-tx-14-"main pulmonary artery"-noun-0]|TX|3778/21|
00000000|MMI|3.47|Gram per Kilogram|C1300563|[qnco]|["mcg/mg"-tx-3-"MCG MG"-noun-0]|TX|775/3,802/2|
00000000|MMI|3.47|Million|C1881839|[qnco]|["10^6"-tx-27-"6/10"-fraction-0]|TX|4752/4|
00000000|MMI|3.47|Pain daily|C3845611|[fndg]|["Pain daily"-tx-3-"Pain DAILY"-noun-0]|TX|816/4,843/5|
00000000|MMI|3.47|Apical segmental vein|C0507238|[bpoc]|["V1"-tx-14-"V1"-noun-0]|TX|3327/2|
00000000|MMI|3.47|LRRC4B gene|C1537594|[gngm]|["HSM"-tx-14-"HSM"-noun-0]|TX|3220/3|
00000000|MMI|3.47|Primary|C0205225|[qlco]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|1253/9|
00000000|MMI|3.47|Randomization Validation|C3889272|[resa]|["RV"-tx-14-"RV"-noun-0]|TX|3504/2|
00000000|MMI|3.47|Structure of right thigh|C0230425|[bpoc]|["RT"-tx-14-"RT"-noun-0]|TX|3224/2|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|1253/9|
00000000|MMI|3.47|V1 stage|C0457422|[fndg]|["V1"-tx-14-"V1"-noun-1]|TX|3327/2|
00000000|MMI|3.47|acute|C0205178|[tmco]|["ACUTE"-tx-14-"acute"-adj-0]|TX|3372/5|
00000000|MMI|3.46|*Constant|C1547014|[qnco]|["*Constant"-tx-3-"constant"-noun-0]|TX|1770/8|
00000000|MMI|3.46|30%|C3842588|[fndg]|["30%"-tx-3-"30"-integer-0]|TX|1045/2|
00000000|MMI|3.46|Constant (qualifier)|C1948059|[qlco]|["Constant"-tx-3-"constant"-noun-0]|TX|1770/8|
00000000|MMI|3.46|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-3-"multiple"-adj-0]|TX|1681/8|
00000000|MMI|3.46|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-3-"p"-adj-0]|TX|1766/1|
00000000|MMI|3.46|P prime|C2603361|[clna]|["P'"-tx-3-"p"-adj-0]|TX|1766/1|
00000000|MMI|3.46|Oral hypoglycemic|C0359086|[phsu]|["Hypoglycemics.oral"-tx-20-"oral hypoglycemics"-noun-0]|TX|4430/18|
00000000|MMI|3.45|Device Events Domain|C3541240|[idcn]|["DE"-tx-1-"De"-noun-0]|TX|87/2|
00000000|MMI|3.45|100%|C3817553|[qnco]|["100%"-tx-3-"100"-integer-0]|TX|472/3|
00000000|MMI|3.45|Every four hours|C0585324|[tmco]|["Q4H"-tx-3-"Q4H"-noun-0]|TX|362/3|
00000000|MMI|3.45|terazosin hydrochloride|C0770137|[orch,phsu]|["terazosin hcl"-tx-3-"TERAZOSIN HCL"-noun-0]|TX|821/13|
00000000|MMI|3.45|Adverse Event Emergency Room Visit|C3810541|[inbe]|["ER"-tx-30-"ER"-noun-0]|TX|4885/2|
00000000|MMI|3.45|Estrogen Receptor Measurement|C3811131|[lbpr]|["ER"-tx-30-"ER"-noun-0]|TX|4885/2|
00000000|MMI|3.45|Mirtazapine 15 MG|C1145809|[clnd]|["Mirtazapine 15 MG"-tx-3-"MIRTAZAPINE 15 MG"-noun-0]|TX|894/17|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-3-"Study"-noun-0]|TX|1302/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-3-"Study"-noun-0]|TX|1302/5|
00000000|MMI|3.45|Every eight hours|C0585326|[tmco]|["Q8H"-tx-3-"Q8H"-noun-0]|TX|808/3|
00000000|MMI|3.44|Immediate Release Dosage Form|C1708470|[bodm]|["Immediate Release"-tx-3-"IMMEDIATE RELEASE"-noun-0]|TX|611/17|
00000000|MMI|3.44|Intrachamber:Pres:Pt:Heart.atrium.right:Qn|C4050168|[clna]|["RA pressure"-tx-14-"RA pressure"-noun-0]|TX|3836/11|
00000000|MMI|3.44|Left side of heart|C0225809|[blor]|["left heart"-tx-9-"left heart"-noun-0]|TX|2222/10|
00000000|MMI|3.44|cardiac event|C0741923|[dsyn]|["cardiac event"-tx-14-"cardiac event"-noun-1]|TX|3924/13|
00000000|MMI|3.44|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-2-"PM"-adj-0]|TX|145/2|
00000000|MMI|3.44|Rest pain|C0234253|[sosy]|["pain rest"-tx-6-"pain rest"-noun-0]|TX|1957/4,1976/4|
00000000|MMI|3.43|CDISC Interventions Class|C3542921|[clas]|["INTERVENTIONS"-tx-17-"interventions"-noun-0]|TX|4239/13|
00000000|MMI|3.43|III (suffix)|C1705160|[qlco]|["III"-tx-14-"III"-noun-0]|TX|3363/3|
00000000|MMI|3.43|Interventions:Finding:Point in time:^Patient:Narrative|C2979881|[clna]|["Interventions"-tx-17-"interventions"-noun-0]|TX|4239/13|
00000000|MMI|3.43|Known|C0205309|[qlco]|["Known"-tx-20-"known"-adj-0]|TX|4416/5|
00000000|MMI|3.43|Offspring|C0680063|[famg]|["kids"-tx-7-"kids"-noun-0]|TX|2069/4|
00000000|MMI|3.43|Recent|C0332185|[tmco]|["Recent"-tx-17-"recent"-adj-0]|TX|4142/6|
00000000|MMI|3.43|Roman Numeral III|C0439070|[inpr]|["III"-tx-14-"III"-noun-0]|TX|3363/3|
00000000|MMI|3.43|EEF2 wt Allele|C1705446|[gngm]|["EF-2"-tx-14-"2 EF"-noun-0]|TX|3435/1,3458/2|
00000000|MMI|3.43|Postural cough|C0231917|[sosy]|["Cough, postural"-tx-13-"cough postural"-noun-1]|TX|2559/5,2572/8|
00000000|MMI|3.43|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-14-"Abd"-noun-0]|TX|3183/3|
00000000|MMI|3.43|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-14-"Abd"-noun-1]|TX|3183/3|
00000000|MMI|3.43|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-3-"BRIEF"-adj-0]|TX|1632/5|
00000000|MMI|3.43|Brief|C1879313|[tmco]|["Brief"-tx-3-"BRIEF"-adj-0]|TX|1632/5|
00000000|MMI|3.43|Shortened|C1282927|[qlco]|["brief"-tx-3-"BRIEF"-adj-0]|TX|1632/5|
00000000|MMI|3.42|Concept History|C1705255|[cnce]|["History"-tx-14-"history"-noun-0]|TX|3901/7|
00000000|MMI|3.42|History of present illness|C0262512|[orga]|["History, NOS"-tx-14-"history"-noun-0]|TX|3901/7|
00000000|MMI|3.42|History of previous events|C2004062|[fndg]|["History"-tx-14-"history"-noun-1]|TX|3901/7|
00000000|MMI|3.42|NPPA gene|C1417807|[gngm]|["PND"-tx-13-"PND"-noun-0]|TX|2523/3|
00000000|MMI|3.42|November|C3828767|[tmco]|["November"-tx-9-"November"-noun-0]|TX|2246/8|
00000000|MMI|3.42|Orthopnea|C0085619|[sosy]|["Orthopnoea"-tx-13-"orthopnea"-noun-0]|TX|2513/9|
00000000|MMI|3.42|Paroxysmal nocturnal dyspnea|C1956415|[dsyn]|["PND"-tx-13-"PND"-noun-0]|TX|2523/3|
00000000|MMI|3.42|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-24-"regimen"-noun-0]|TX|4657/7|
00000000|MMI|3.42|Anxiety Scale (BASC-2)|C4050613|[inpr]|["Anxiety"-tx-19-"anxiety"-noun-0]|TX|4367/7|
00000000|MMI|3.42|Hour|C0439227|[tmco]|["HOURS"-tx-6-"hours"-noun-0]|TX|1987/5|
00000000|MMI|3.42|Increase|C0442805|[ftcn]|["Increased"-tx-19-"increased"-adj-0]|TX|4357/9|
00000000|MMI|3.42|Increased|C0205217|[qnco]|["Increased"-tx-19-"increased"-adj-0]|TX|4357/9|
00000000|MMI|3.42|Bedtime (qualifier value)|C0521112|[tmco]|["Bedtime"-tx